Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.
about
Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.Nuclear factor one transcription factors as epigenetic regulators in cancer.Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer.NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancerFamily matters: How MYC family oncogenes impact small cell lung cancer.Recalcitrant small cell lung cancer: the argument for optimism.Transcription Factor and lncRNA Regulatory Networks Identify Key Elements in Lung Adenocarcinoma.Microarray analysis to identify the similarities and differences of pathogenesis between aortic occlusive disease and abdominal aortic aneurysm.Small-cell lung cancer: what we know, what we need to know and the path forward.Non-small cell lung cancer: miR-30d suppresses tumor invasion and migration by directly targeting NFIB.Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma.Small-cell lung cancer in 2016: Shining light on novel targets and therapies.Tumor heterogeneity in small cell lung cancer defined and investigated in pre-clinical mouse models.Transcriptional deregulation underlying the pathogenesis of small cell lung cancer.Survival Outcomes for Patients with Surgical and Non-Surgical Treatments in Stages I-III Small-Cell Lung Cancer.
P2860
Q30235105-1C0E73CD-9DAC-4E61-BC63-9217C1E304B2Q33809465-731257D0-EE4C-457C-90AF-92862CB68116Q39019412-2295CBC8-805E-4AE3-9DE4-C3EC127D9BCCQ39079853-68F312DA-9C66-4F3F-AF28-CFE0ED186D30Q39360520-6DC6988D-D2C1-41AF-9154-98AB2D0A38D8Q39404684-9C0B5C17-95FC-4DA6-A82C-91E4D76A04C7Q39454070-961F1298-4393-4BE9-BD21-226B29097164Q42362314-F82958D1-05AA-4746-A6FC-4260AD189C0FQ47198740-756347E0-E48B-414C-AA0F-952E5D324009Q47583785-ED0A3D2B-E2FD-4169-84A2-44870473F8E0Q47595394-D27F3157-B511-418D-8428-5E80C3423986Q50238145-B51E39DA-D19C-4148-BB19-75599ACD3BD9Q52724198-F622B821-D7CC-408E-9939-6E9FFF80E8A8Q52813956-4260CD91-7720-4FA3-8740-EF00F9F2D969Q53702193-7FBC06E2-D8C9-42CF-9347-A08487C57FF3Q55011897-FAD9E85B-D5AB-48C9-B2D6-4DA65166775FQ55287358-EA8B2443-714E-4A42-91FB-2ADBF7CC6F12
P2860
Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transcription Factor NFIB Is a ...... etastatic Disease in Patients.
@en
Transcription Factor NFIB Is a ...... etastatic Disease in Patients.
@nl
type
label
Transcription Factor NFIB Is a ...... etastatic Disease in Patients.
@en
Transcription Factor NFIB Is a ...... etastatic Disease in Patients.
@nl
prefLabel
Transcription Factor NFIB Is a ...... etastatic Disease in Patients.
@en
Transcription Factor NFIB Is a ...... etastatic Disease in Patients.
@nl
P2093
P2860
P1433
P1476
Transcription Factor NFIB Is a ...... etastatic Disease in Patients.
@en
P2093
Anton Berns
Colin Pritchard
Dennis Peters
Egbert F Smit
Ekaterina A Semenova
Erwin van Montfort
Ivo J Huijbers
Jan van der Vliet
Jan-Paul Lambooij
Ji-Ying Song
P2860
P304
P356
10.1016/J.CELREP.2016.06.020
P50
P577
2016-06-29T00:00:00Z